These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 10693867)

  • 21. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis.
    Furumitsu Y; Inaba M; Yukioka K; Yukioka M; Kumeda Y; Azuma Y; Ohta T; Ochi T; Nishizawa Y; Morii H
    J Rheumatol; 2000 Jan; 27(1):64-70. PubMed ID: 10648019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.
    Partsch G; Steiner G; Leeb BF; Dunky A; Bröll H; Smolen JS
    J Rheumatol; 1997 Mar; 24(3):518-23. PubMed ID: 9058659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
    Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
    J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line.
    Lehmann T; Nguyen LQ; Handel ML
    J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
    Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
    J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
    Miller LE; Grifka J; Schölmerich J; Straub RH
    J Rheumatol; 2002 Mar; 29(3):427-35. PubMed ID: 11908553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
    Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
    Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis.
    Schedel J; Wenglén C; Distler O; Müller-Ladner U; Schölmerich J; Heinegård D; Krenn V
    Scand J Immunol; 2004 Nov; 60(5):514-23. PubMed ID: 15541045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.